• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评论:迈向清晰、基于证据且有效的成瘾医学国家政策。

Commentary: Moving Toward Clear, Evidence-based, and Effective State Policies for Addiction Medicine.

作者信息

Thomas Cindy Parks

机构信息

Heller Graduate School for Social Policy and Management, Brandeis University, Waltham, MA.

出版信息

J Addict Med. 2022;16(2):130-131. doi: 10.1097/ADM.0000000000000862.

DOI:10.1097/ADM.0000000000000862
PMID:34014208
Abstract

State policies play a critical role in determining health care delivery, health equity, and health outcomes, but vary widely in scope, target, restrictiveness, and goals. Understanding how such policies impact health care is critical to development of evidence-based policies, but difficult in the absence of organized and standardized approaches to analysis. Development of themes and frameworks for analysis, and identification of policies supported by evidence, are important steps in moving toward more rational and aligned policies. Buprenorphine treatment for opioid use disorder provides a good example and methodological foundation. At the same time, state policies are promulgated within a larger policy, treatment, and socio-economic environment, and these influences must be considered as well.

摘要

国家政策在决定医疗服务提供、健康公平性和健康结果方面发挥着关键作用,但在范围、目标、限制性和目标方面差异很大。了解此类政策如何影响医疗保健对于制定循证政策至关重要,但在缺乏有组织和标准化的分析方法的情况下却很困难。制定分析主题和框架以及确定有证据支持的政策是朝着更合理和协调一致的政策迈进的重要步骤。丁丙诺啡用于治疗阿片类物质使用障碍就是一个很好的例子和方法基础。与此同时,国家政策是在更大的政策、治疗和社会经济环境中颁布的,这些影响也必须予以考虑。

相似文献

1
Commentary: Moving Toward Clear, Evidence-based, and Effective State Policies for Addiction Medicine.评论:迈向清晰、基于证据且有效的成瘾医学国家政策。
J Addict Med. 2022;16(2):130-131. doi: 10.1097/ADM.0000000000000862.
2
Policies related to opioid agonist therapy for opioid use disorders: The evolution of state policies from 2004 to 2013.与阿片类物质使用障碍的阿片类激动剂治疗相关的政策:2004年至2013年各州政策的演变
Subst Abus. 2016;37(1):63-9. doi: 10.1080/08897077.2015.1080208. Epub 2015 Nov 13.
3
Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.从监禁中获释、复吸阿片类药物以及丁丙诺啡维持治疗的可能性:对患有阿片类药物使用障碍的前囚犯认知的定性研究
Addict Sci Clin Pract. 2015 Jan 16;10(1):2. doi: 10.1186/s13722-014-0023-0.
4
Implementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.在成瘾治疗中应用丁丙诺啡:俄亥俄州支付方和医疗服务提供者的观点
Subst Abuse Treat Prev Policy. 2015 Mar 28;10:13. doi: 10.1186/s13011-015-0009-2.
5
Training in office-based opioid treatment with buprenorphine in US residency programs: A national survey of residency program directors.美国住院医师培训项目中使用丁丙诺啡进行基于办公室的阿片类药物治疗的培训:对住院医师培训项目主任的全国性调查。
Subst Abus. 2018;39(4):434-440. doi: 10.1080/08897077.2018.1449047. Epub 2018 May 14.
6
Integrating addiction medicine into rural primary care: Strategies and initial outcomes.将成瘾医学融入农村基层医疗保健:策略和初步成果。
J Consult Clin Psychol. 2019 Oct;87(10):952-961. doi: 10.1037/ccp0000410.
7
President's message.校长致辞。
J Addict Dis. 2021 Oct-Dec;39(4):433-435. doi: 10.1080/10550887.2021.1976372. Epub 2021 Oct 20.
8
Buprenorphine Prescribing and Dosing Limits: Evidence and Policy Goals.丁丙诺啡的处方和剂量限制:证据与政策目标。
Subst Abus. 2023 Jan-Apr;44(1):17-23. doi: 10.1177/08897077231165619. Epub 2023 Apr 26.
9
Eliminating the buprenorphine DEA X waiver is critical to promote health equity.取消丁丙诺啡的美国药品监督管理局(DEA)X类豁免对于促进健康公平至关重要。
Nurs Outlook. 2022 Jan-Feb;70(1):5-7. doi: 10.1016/j.outlook.2021.10.003. Epub 2021 Dec 8.
10
Beyond Buprenorphine: Models of Follow-up Care for Opioid Use Disorder in the Emergeny Department.超越丁丙诺啡:急诊科阿片类药物使用障碍的随访护理模式。
West J Emerg Med. 2020 Nov 2;21(6):257-263. doi: 10.5811/westjem.2020.7.46079.